A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer.

Front Nutr · 2018 · PMC6336921 · PMID 30687714

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our data about the absence of effect of curcumin on MDSC frequencies in blood are in contrast with a report in the 4T1 mouse model where curcumin showed a trend toward MDSC reduction in blood (predominantly granulocytic MDSC), which became significant when curcumin was combined with a listeria vaccine ( 42 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.